SAFETY, EFFICACY, AND EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED OR REFRACTORY CD30+ HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A SYSTEMATIC REVIEW. REMUNOM [Internet]. 2026 Feb. 19 [cited 2026 Feb. 25];2(02):1-23. Available from: https://remunom.ojsbr.com/multidisciplinar/article/view/5503